Highly parallelized scRNA-seq pipelines are now becoming the standard. In many current and 1 proposed studies, thousands to millions of cells are sequenced, with each cell receiving low 2 coverage. At low coverages of 500-1000 unique molecular identifiers (UMI) per cell, precise 3 distinctions between cell states are blurred and genes with low expression cannot be accurately 4 quantified. To address this challenge, methods have been developed to de-noise and impute 5 scRNA-seq data [4] [5] [6] [7] . These methods, however, may not perform well when sequencing is done at 6 extremely low depth, or when applied to cell types that are rare. Notably, existing denoising 7 techniques act solely upon the data from a given study and ignore existing datasets in public 8 domain, which may contain similar cell types. 9
In light of the Human Cell Atlas initiative 8 , the scientific community will soon have detailed atlases 10 for each anatomic organ in the human body; for the laboratory mouse, such an atlas (Tabula Muris) 11 was recently unveiled 9 . Accumulation of publicly available scRNA-seq data presents an opportunity 12 to leverage existing data in the denoising of a new scRNA-seq data set. Yet, it is unclear how much 13 information can be borrowed across datasets which might be generated using different platforms, 14 wherein samples are processed differently or at different coverages. Moreover, such transfer 15 learning must guarantee that the denoising process will not introduce bias or force the new data to 16 lose its distinctive features and conform to the patterns in existing data. 17
Here we describe a denoising framework, called Single-cell Analysis via Expression Recovery 18 harnessing eXternal data (SAVER-X). It uses the deep autoencoder, a neural network that achieves 19 noise reduction by means of an information bottleneck 10 . Consider a target dataset to be denoised. 20
The autoencoder can be trained on this data starting either from random initialization of the weights, 21 as in other denoising tools like DCA 7 , or from weights obtained by training on existing public data 22 sets (pre-training data; Figure 1b ) with related cell types. The latter -initialization by pre-trained 23
weights followed by refinement on the test data -transfers information from public data to a user's 24 current dataset. 25 disease conditions. By pre-training SAVER-X on scRNA-seq data from the Human Cell Atlas (HCA) 1 project 8 (500,000 immunocytes from umbilical cord blood and bone marrow) and 10X Genomics 2 website 16 (200,000 peripheral blood Mmononuclear cells), we were able to meaningfully improve 3 the data quality in other scRNA-seq studies that profiled immune cells. 4
First, we evaluated SAVER-X with and without pre-training against existing denoising methods on a 5 set of purified cells from 9 immune cell types 16 . We created a "test" dataset by randomly selecting 6 100 cells for each cell type (Online Methods). Among this set of 900 immune cells, with an average 7 UMI count of roughly 1200 per cell, neither is it easy to visually distinguish NK cells from T-cells, nor 8 can T-cell subtypes be separated (Figure 2a ). SAVER-X imputation of this dataset, without using 9 any existing data for pretraining, enhances the separation of NK cells from T-cells. Although the 10 visualization of intra T-cell subtype heterogeneity also improves, the subtypes remain difficult to 11
identify. The impact of transfer learning becomes apparent when we denoise the test data using 12 SAVER-X pre-trained on the HCA data ( Figure 2a , and yet the mechanisms underlying their 23 establishment and maturation remain elusive. SAVER-X allows us to confidently identify this sub-24 population and study its homeostasis, which is ultimately critical for clinical applications in both 25 vaccination and immune reconstitution.
The potential of transfer learning in biology hinges on its ability to adapt to diverse and practical 1 settings. Thus, we explored if SAVER-X can effectively learn from healthy HCA cells in the 2 denoising of immune cells sequenced from primary breast carcinoma samples from eight treatment-3 naïve patients 18 . SAVER-X, pre-trained on publicly available immune cell datasets to denoise the 4 tumor tissue-resident immune cells, not only allowed us to better characterize immune cell types, 5 but also clarified the expression patterns of marker genes ( Figure 2b , Figure S3 ) in these patients. 6
This improved reconstruction of the tumor immune microenvironment typifies the potential gains 7 achievable by transfer learning from accumulating public data. 8
We further assessed the utility of SAVER-X in scenarios where either the number of cells 9 sequenced could be small (less than 100), or the sequencing depth might be too low (60 UMIs per 10 cell; Table S1 ). Currently, cells with such low coverage are typically discarded. We show that 11 SAVER-X not only salvages such data, but also extracts useful information about gene-gene 12 relationships ( Figure S2 ). We benchmarked SAVER-X against other scRNA-seq denoising methods 13 that do not employ transfer learning, viz., DCA Having demonstrated that SAVER-X effectively transfers information across labs and from healthy 20 to disease settings, we next examined the feasibility of transfer learning across species. Mouse 21 models have helped scientists understand the basis of several human disorders, and although 22 transcriptomic patterns in mouse might not always provide a direct route to the cognate human 23 condition, similarities and disparities of genetic programs, once understood, are likely to provide a 24 deeper understanding of the fundamental architecture underlying cellular development and 25 physiology. In this regard, the ability to harness mouse data in the denoising of human datadeveloping ventral midbrain of both human and mouse, and found that, indeed, SAVER-X pre-1 trained on mouse scRNA-seq data enhances the quality of the human data ( Figure 3) . 2 First, we reduced the high coverage human ventral midbrain scRNA-seq data by sampling only 10% 3 of the reads 13 , to a median per cell coverage of 452 UMIs. To compare the gains achievable by 4 intra-and inter-species transfer learning, we split the human cells randomly into two groups, down-5 sampled one group and used the other group as the pre-training data (Figure 3a) . SAVER-X pre-6 trained on the matched mouse brain cells led to a distinct improvement in cell type identification for 7 human compared with the un-pretrained model, affirming the potential of transfer learning across 8 species (Figure 3b) . We found that a model jointly pre-trained on both human and mouse data 9 further augments the human scRNA-seq data quality compared with pre-training on the human cells 10 alone. Remarkably, pre-training SAVER-X on cells from regions other than the ventral mid-brain 11 using the Tabula Muris 9 also improved the ARI (Figure 3b ). We then pre-trained SAVER-X on three 12 human non-UMI datasets [19] [20] [21] , and found that the model jointly pre-trained using both the non-UMI 13 human cells and mouse cells outperforms training on either species alone ( Figure S4a ). These 14 observations suggest that SAVER-X prevents negative transfer of information between species by 15 harnessing the heterogeneity among public datasets. Data heterogeneity forces SAVER-X to learn 16 robust low-dimensional representation of information, which likely contains the true biological 17 signals that are shared across studies. 18
To further demonstrate that SAVER-X does not unnaturally bias data denoising, we examined 19 whether a model pre-trained on mouse data affects human-specific patterns. We denoised human 20 scRNA-seq data using the matched mouse data, and then compared the log fold-change of the 21 genes differentially expressed between human and mouse for each cell type before and after 22 denoising. We found that the fold changes are indeed preserved, suggesting that SAVER-X 23 introduces negligible bias (Figure 3c ). On the other hand, simply relying on an autoencoder, without 24 gene filtering or Bayesian shrinkage, reduces the fold change between human and mouse for some 25 genes in some cell types ( Figure S4b ). This highlights the importance of balancing the autoencoder 26 predictions against the observed data to prevent bias.
Taken together, our results demonstrate that the transfer learning framework employed by SAVER-1 X can leverage existing scRNA-seq datasets to improve the quality of new scRNA-seq data across 2 UMI-based sequencing platforms, species, organs and cell types. At its core, SAVER-X trains a 3 deep neural network on scRNA-seq data across a range of study designs and applies this model to 4 new data to strengthen shared biological patterns. This general framework for inferring "true" 5 relationships from raw and error-prone experimental data will be broadly applicable in other high-6 throughput settings. Through applications in immunology and developmental neuroscience, we 7
show that SAVER-X can improve cell type classification and gene expression characterization in 8 both healthy and disease settings. With increasing accumulation of publicly available data, SAVER-9 X will increase in generalization accuracy and in tissue-and cell-type specificity. A technology like 10 SAVER-X changes the approach to scRNA-seq data analysis from a process of study-specific 11 quality control and statistical modeling to an automated process of cross-study data integration and 12 information sharing. 13
14

Methods
15
Collection of public datasets 16
The Human Cell Atlas (HCA) dataset was downloaded from the HCA data portal 17 (https://preview.data.humancellatlas.org/) and the PBMC data was downloaded from the 10X 18 website (https://support.10xgenomics.com/single-cell-gene-expression/datasets, Table S2 ). The 19 purified data for each immune cell type was also downloaded from the 10X website 16 . The breast 20 cancer data 18 was downloaded from GEO (GSE114725). The developing midbrain data 13 was 21 downloaded from GEO (GSE76381). For other mouse developing brain datasets, we include cells 22 from neonatal and fetal brain tissues in the Tabula Muris 9 data (GSE108097). For the other non-23 UMI human developing brain datasets, we include three: GSE75140 20 , GSE104276 21 and 24 19 . No filtering is done on the original data and all genes and cells provided in the 25 original datasets were used by SAVER-X.
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A complete list of the pre-training datasets used for pre-training the models on the SAVER-X 1 website is provided in Table S2 . 2
Details of SAVER-X 3
SAVER-X uses a Bayesian hierarchical model to combine evidence from the raw read counts of a 4 new data set with predictions made by an autoencoder. The autoencoder can be trained exclusively 5 on the new data set, or first pre-trained on existing data sets and then on the new data set. The 6 autoencoder used by SAVER-X has three subnetworks, as shown in Figure 1a For UMI datasets, let the raw UMI count for each cell and gene be , then the input expression 17 levels are normalized by library size, re-scaled and log-transformed using formula: � = 18 log� / × 10000 + 1� where = ∑ is the library size of cell . For non-UMI datasets, TPM 19 for each cell and gene are denoted as , and then the are transformed using the same 20 formula as that for UMI. If a gene is missing in the dataset, the input is set to 0 while the 21 corresponding output node is not accounted for in the loss function. Specifically, let the output value 22 for gene be defined as � , which we refer to as the autoencoder prediction. Conditional on the 23 prediction � , the observed UMI count is assumed to follow a Negative Binomial distribution. Thus,
node presents in the dataset
1
On the other hand, TPM data is assumed to approximately follow a zero inflated Negative Binomial 2 distribution (although TPM is not integer-valued, the likelihood function can still be computed) and 3 the loss is defined as: 4
node presents in the dataset 5 where NB( ; , ) and ZINB( ; , , ) are the density of Negative Binomial and zero-inflated 6
Negative Binomial distributions (see Supplementary Note). A separate gene-specific dispersion 7 parameter and is dedicated for UMI and non-UMI input, respectively. For non-UMI data, the 8 gene-and cell-specific zero inflation parameter is defined as 9
Our implementation of the autoencoder builds on top of the source code of DCA 7 , using its library 11
functions. 12
Although SAVER-X accepts pre-training data both with and without UMI, the target data must 13 have UMI. When SAVER-X is applied to the denoising of a UMI-based target data matrix, the 14 following steps are applied (Figure 1a) : (1) The autoencoder is fit on the target data, optionally 15 starting with a user-selected pre-trained model. (2) Cross-validation is applied to filter out genes 16
that cannot be predicted well by the autoencoder. Specifically, the target data is randomly split into 17 held-in and held-out cell sets, the autoencoder is trained on the held-in set and then used to make 18 predictions on the held-out set. For a specific gene , let the normalized predictions using the held-19 in set trained model on a held-out cell is � and let the held-in sample mean for the library-size 20 normalized counts be . Then a gene is unpredictable if the Poisson deviance of the predictions 21
and original UMI counts of the held-out samples is larger than that of the held-in sample mean and . In SAVER, let be the true relative expression 6 level of the gene that we want to recover, then we assume 7
where is the rate parameter, = � is the shape parameter and � is the filtered 9 autoencoder prediction. The final denoised expression level of a gene in each cell is a weighted 10 average of the autoencoder predicted value and its observed UMI count: 11
̂= +̂++̂� 12
Where ̂ is obtained by maximizing the likelihood in SAVER. 13
Data denoising using other bench-marking methods 14 
Generating down-sampled datasets 19
For an observed UMI count data matrix, we down-sample the reads to obtain a data set of the same 20 gene and cell numbers but with lower quality. For cell and gene , the down-sampled value is 21 generated by independently drawing from a Poisson distribution with ~Poisson( ) whereis a cell-specific efficiency loss. To mimic variation in efficiency across cells, we sampled as 1 follows: 2 1. 10% efficiency: ~Gamma(10, 100), used on the mouse midbrain data 13 3 2. 5% efficiency: ~Gamma(5, 100), used on the 10X PBMC data 16 4 t-SNE visualization and cell clustering 5
We used Seurat version 2.0 to perform cell clustering and t-SNE visualization according to the 6 workflow detailed at (https://satijalab.org/seurat/pbmc3k_tutorial.html). For all analyses, we set the 7 number of principal components to 15. For cell clustering using Seurat, resolution is set to be 1.6, 
Differential expression analysis 13
Differentially expressed genes between human and mouse for each cell type of the developing 14 midbrain are obtained also using Seurat 2.0, where the Wilcoxon rank sum test is used. P-value 15 adjustment is performed using Bonferroni correction based on the total number of genes in the 16 dataset. A gene is selected as differentially expressed if its adjusted p-value is ≤ 0.05 and the 17 absolute log fold change is ≥ 0.25. 18
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The authors declare no competing interests 21 Figure 1 : Outline of the SAVER-X transfer learning framework. a) Online learning: User uploads data (UMI count matrix) to the SAVER-X web portal (1) and chooses a desired pre-trained model (2A). The model is trained with the user data. Filtering of unpredictive genes (2B) and empirical Bayes shrinkage (2C) are then performed to prevent overfitting. User finally receives a denoised data matrix of the same size as the input data matrix (3), which can be used for downstream analysis. b) Offline autoencoder pre-training: for each species and each organ/cell-type, public datasets are collected and combined to train an autoencoder to generate pre-trained weights. c) Architecture of the autoencoder: The autoencoder allows cells from both human and mouse, both with and without UMI, to be used for pre-training. However, For each species, there are about 20,000 input nodes accepting raw gene expression values; approximately two-thirds of the input nodes are shared between species for genes with homologs.
Figure 2: SAVER-X de-noising of immune cell subsets a) t-SNE plots of 900 immune cells, colored by known cell-type labels, from the original data, and the denoised data using de-noising models with and without transfer learning are shown. The number at the right-bottom corner of each plot is the adjusted rand index (ARI). b) Infiltrating immune cells in resected breast carcinoma from two breast cancer patients from Azizi et al. The three panels show visualizations using original data, denoised values by SAVER-X without pre-training, and denoised values by SAVER-X pre-trained on HCA and 10X PBMC data. The t-SNE plots show separation between cell types (cell labels are obtained from the original paper). Feature plots show the expression of known marker genes, and a darker red color represents a relatively higher expression level. c) The performance of SAVER-X is benchmarked against existing imputation methods using clustering ARI. Each experiment varies the number of cells and the sequencing coverage. d) Relative expression of known marker genes in 5000 PBMC T cells (from the 9000 PBMC cells experiment) before and after denoising using SAVER-X.
